Home » Analyst Articles – US
COMPASS Pathways’ (CMPS) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a research note released on Monday morning, Benzinga reports. They currently have a $120.00 target price on the stock. Several... More of this article »
Wedbush Boosts Crocs (NASDAQ:CROX) Price Target to $170.00
Crocs (NASDAQ:CROX – Free Report) had its price objective increased by Wedbush from $156.00 to $170.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have an outperform rating on the... More of this article »
Oppenheimer Upgrades Sarepta Therapeutics (NASDAQ:SRPT) to “Outperform”
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) was upgraded by Oppenheimer from a “market perform” rating to an “outperform” rating in a report issued on Tuesday, Marketbeat.com reports. The firm... More of this article »
Ulta Beauty (NASDAQ:ULTA) PT Lowered to $476.00 at The Goldman Sachs Group
Ulta Beauty (NASDAQ:ULTA – Get Free Report) had its price target cut by The Goldman Sachs Group from $605.00 to $476.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “neutral”... More of this article »
Shimmick (NASDAQ:SHIM) Downgraded by Roth Mkm
Shimmick (NASDAQ:SHIM – Get Free Report) was downgraded by analysts at Roth Mkm from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat.com reports. They currently have... More of this article »
Oppenheimer Raises Agilysys (NASDAQ:AGYS) Price Target to $100.00
Agilysys (NASDAQ:AGYS – Get Free Report) had its price target boosted by stock analysts at Oppenheimer from $95.00 to $100.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has an “outperform”... More of this article »
Manhattan Associates (NASDAQ:MANH) Now Covered by Redburn Atlantic
Investment analysts at Redburn Atlantic started coverage on shares of Manhattan Associates (NASDAQ:MANH – Get Free Report) in a research report issued on Tuesday, Benzinga reports. The firm set a “buy” rating and... More of this article »
Beyond (NYSE:BYON) Stock Rating Reaffirmed by Wedbush
Beyond (NYSE:BYON – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at Wedbush in a research note issued on Tuesday, Benzinga reports. They presently have a $37.00 price target... More of this article »
Ikena Oncology’s (IKNA) Outperform Rating Reiterated at Wedbush
Ikena Oncology (NASDAQ:IKNA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Wedbush in a research note issued on Tuesday, Benzinga reports. They currently have... More of this article »
Pixelworks (NASDAQ:PXLW) Downgraded by StockNews.com to Sell
StockNews.com cut shares of Pixelworks (NASDAQ:PXLW – Free Report) from a hold rating to a sell rating in a research report report published on Monday morning. Separately, Needham & Company LLC lifted their target price... More of this article »
Tyson Foods (NYSE:TSN) Upgraded to Buy at StockNews.com
StockNews.com upgraded shares of Tyson Foods (NYSE:TSN – Free Report) from a hold rating to a buy rating in a research report released on Monday morning. A number of other equities research analysts have also issued reports on... More of this article »
Fortive (NYSE:FTV) Raised to “Buy” at StockNews.com
StockNews.com upgraded shares of Fortive (NYSE:FTV – Free Report) from a hold rating to a buy rating in a report published on Monday. FTV has been the subject of several other reports. Truist Financial began coverage on shares... More of this article »
Tantech (NASDAQ:TANH) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Tantech (NASDAQ:TANH – Free Report) in a research note released on Monday. The firm issued a sell rating on the basic materials company’s stock. Tantech Trading Down 1.2 % NASDAQ... More of this article »
TScan Therapeutics’ (TCRX) Outperform Rating Reaffirmed at Wedbush
Wedbush restated their outperform rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note issued to investors on Monday, RTT News reports. Wedbush currently has a $10.00 price objective on the stock. A... More of this article »
Service Properties Trust (NASDAQ:SVC) Price Target Cut to $9.00 by Analysts at B. Riley
Service Properties Trust (NASDAQ:SVC – Free Report) had its price objective lowered by B. Riley from $10.00 to $9.00 in a research note released on Monday morning, Benzinga reports. The brokerage currently has a buy rating on... More of this article »
SoundHound AI’s (SOUN) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of SoundHound AI (NASDAQ:SOUN – Free Report) in a research report released on Monday, Benzinga reports. The brokerage currently has a $7.00 price target on the stock. Several... More of this article »
Qualys (NASDAQ:QLYS) Receives “Hold” Rating from Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Qualys (NASDAQ:QLYS – Free Report) in a research report sent to investors on Monday, Benzinga reports. Other research analysts have also issued research reports... More of this article »
Evercore ISI Initiates Coverage on Arcellx (NASDAQ:ACLX)
Equities research analysts at Evercore ISI assumed coverage on shares of Arcellx (NASDAQ:ACLX – Get Free Report) in a research report issued on Tuesday, Benzinga reports. The firm set an “outperform” rating and a... More of this article »
Neurocrine Biosciences (NASDAQ:NBIX) Earns Outperform Rating from Analysts at Evercore ISI
Equities research analysts at Evercore ISI began coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) in a research report issued on Tuesday, Benzinga reports. The firm set an “outperform”... More of this article »
Advanced Micro Devices (NASDAQ:AMD) Receives New Coverage from Analysts at Jefferies Financial Group
Jefferies Financial Group assumed coverage on shares of Advanced Micro Devices (NASDAQ:AMD – Free Report) in a research note published on Monday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $190.00... More of this article »
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target Cut to $27.00 by Analysts at Morgan Stanley
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) had its price objective reduced by Morgan Stanley from $36.00 to $27.00 in a research note released on Monday morning, Benzinga reports. Morgan Stanley currently has an equal... More of this article »
Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Cut to $3.00
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) had its price objective lowered by Mizuho from $4.00 to $3.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a “neutral”... More of this article »
Stifel Nicolaus Increases Allogene Therapeutics (NASDAQ:ALLO) Price Target to $4.60
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) had its price objective hoisted by Stifel Nicolaus from $4.40 to $4.60 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “hold”... More of this article »
Coterra Energy (NYSE:CTRA) PT Raised to $39.00 at Piper Sandler
Coterra Energy (NYSE:CTRA – Get Free Report) had its price target boosted by Piper Sandler from $37.00 to $39.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has an “overweight” rating... More of this article »
Augmedix (NASDAQ:AUGX) Downgraded to “Inline” at Evercore ISI
Augmedix (NASDAQ:AUGX – Get Free Report) was downgraded by stock analysts at Evercore ISI from an “outperform” rating to an “inline” rating in a report released on Tuesday, Briefing.com reports. They presently... More of this article »
BMO Capital Markets Boosts CMS Energy (NYSE:CMS) Price Target to $71.00
CMS Energy (NYSE:CMS – Get Free Report) had its target price lifted by analysts at BMO Capital Markets from $68.00 to $71.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has an “outperform”... More of this article »
Stephens Initiates Coverage on Blueprint Medicines (NASDAQ:BPMC)
Stock analysts at Stephens initiated coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Get Free Report) in a report released on Tuesday, MarketBeat.com reports. The firm set an “overweight” rating and a $140.00... More of this article »
Paysafe (NYSE:PSFE) Price Target Increased to $16.00 by Analysts at Susquehanna
Paysafe (NYSE:PSFE – Get Free Report) had its price target increased by Susquehanna from $14.00 to $16.00 in a report issued on Tuesday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Susquehanna’s... More of this article »
Delcath Systems (NASDAQ:DCTH) Research Coverage Started at Stephens
Equities research analysts at Stephens assumed coverage on shares of Delcath Systems (NASDAQ:DCTH – Get Free Report) in a research note issued on Tuesday, Briefing.com reports. The brokerage set an “overweight” rating... More of this article »
Perspective Therapeutics (NYSEAMERICAN:CATX) Coverage Initiated by Analysts at Royal Bank of Canada
Equities researchers at Royal Bank of Canada assumed coverage on shares of Perspective Therapeutics (NYSEAMERICAN:CATX – Get Free Report) in a report released on Tuesday, Benzinga reports. The firm set an “outperform”... More of this article »
Piper Sandler Raises EOG Resources (NYSE:EOG) Price Target to $154.00
EOG Resources (NYSE:EOG – Get Free Report) had its target price increased by equities research analysts at Piper Sandler from $153.00 to $154.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has... More of this article »
Western Digital (NASDAQ:WDC) Now Covered by Analysts at Citigroup
Stock analysts at Citigroup started coverage on shares of Western Digital (NASDAQ:WDC – Get Free Report) in a research report issued to clients and investors on Tuesday, Briefing.com reports. The brokerage set a “buy”... More of this article »
Terns Pharmaceuticals (NASDAQ:TERN) Rating Reiterated by HC Wainwright
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “neutral” rating restated by equities research analysts at HC Wainwright in a report issued on Tuesday, Benzinga reports. They currently... More of this article »
Sutro Biopharma (NASDAQ:STRO) Receives Buy Rating from HC Wainwright
Sutro Biopharma (NASDAQ:STRO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They currently have a $12.00... More of this article »
Stephens Initiates Coverage on Sensei Biotherapeutics (NASDAQ:SNSE)
Equities research analysts at Stephens assumed coverage on shares of Sensei Biotherapeutics (NASDAQ:SNSE – Get Free Report) in a report issued on Tuesday, Benzinga reports. The brokerage set an “overweight” rating... More of this article »
Praxis Precision Medicines (NASDAQ:PRAX) Receives “Buy” Rating from HC Wainwright
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research report issued on Tuesday, Benzinga reports. They presently... More of this article »
B. Riley Initiates Coverage on Veru (NASDAQ:VERU)
Equities researchers at B. Riley assumed coverage on shares of Veru (NASDAQ:VERU – Get Free Report) in a research report issued on Tuesday, Benzinga reports. The firm set a “buy” rating and a $5.00 price target on... More of this article »
Amicus Therapeutics (NASDAQ:FOLD) Upgraded by Guggenheim to “Buy”
Amicus Therapeutics (NASDAQ:FOLD – Get Free Report) was upgraded by analysts at Guggenheim from a “neutral” rating to a “buy” rating in a research note issued on Tuesday, MarketBeat reports. The firm presently... More of this article »
Fulcrum Therapeutics (NASDAQ:FULC) Receives Buy Rating from HC Wainwright
Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday, Benzinga reports. They presently have a $17.00... More of this article »
Insmed (NASDAQ:INSM) Given “Buy” Rating at HC Wainwright
Insmed (NASDAQ:INSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have... More of this article »
Natera (NASDAQ:NTRA) Price Target Raised to $120.00
Natera (NASDAQ:NTRA – Get Free Report) had its price objective boosted by stock analysts at Piper Sandler from $110.00 to $120.00 in a report issued on Tuesday, Benzinga reports. The firm presently has an “overweight”... More of this article »
Nexstar Media Group (NASDAQ:NXST) Upgraded to Overweight by Wells Fargo & Company
Wells Fargo & Company upgraded shares of Nexstar Media Group (NASDAQ:NXST – Free Report) from an equal weight rating to an overweight rating in a research report sent to investors on Monday, MarketBeat reports. The firm... More of this article »
PENN Entertainment (NASDAQ:PENN) Cut to “Neutral” at Bank of America
Bank of America downgraded shares of PENN Entertainment (NASDAQ:PENN – Free Report) from a buy rating to a neutral rating in a report published on Monday morning, MarketBeat Ratings reports. The firm currently has $17.50 price... More of this article »
GLOBALFOUNDRIES (NASDAQ:GFS) Receives New Coverage from Analysts at Jefferies Financial Group
Jefferies Financial Group began coverage on shares of GLOBALFOUNDRIES (NASDAQ:GFS – Free Report) in a report released on Monday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $62.00 price objective... More of this article »
DNOW (NYSE:DNOW) PT Lowered to $15.00 at Susquehanna
DNOW (NYSE:DNOW – Free Report) had its price objective decreased by Susquehanna from $16.00 to $15.00 in a report issued on Monday morning, Benzinga reports. Susquehanna currently has a neutral rating on the oil and gas company’s... More of this article »
Lam Research (NASDAQ:LRCX) Coverage Initiated by Analysts at Jefferies Financial Group
Jefferies Financial Group began coverage on shares of Lam Research (NASDAQ:LRCX – Free Report) in a research note published on Monday morning, Marketbeat reports. The brokerage issued a buy rating and a $1,100.00 price objective... More of this article »
Rapid7 (NASDAQ:RPD) Price Target Cut to $40.00 by Analysts at Susquehanna
Rapid7 (NASDAQ:RPD – Free Report) had its price target trimmed by Susquehanna from $55.00 to $40.00 in a report released on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the technology company’s... More of this article »
Royal Bank of Canada (NYSE:RY) Upgraded by Jefferies Financial Group to “Buy”
Jefferies Financial Group upgraded shares of Royal Bank of Canada (NYSE:RY – Free Report) (TSE:RY) from a hold rating to a buy rating in a research report sent to investors on Monday, Marketbeat reports. RY has been the subject... More of this article »